Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Sanderson Study: A Diagnostic Case-Control Study for the Development of Multiomics Blood Tests for Cancer Screening in a Real World Setting

NCT05516927 is registered in ClinicalTrials.gov with Freenome Holdings Inc. as lead sponsor.

NCT NCT05516927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05516927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Sanderson Study: A Diagnostic Case-Control Study for the Development of Multiomics Blood Tests for Cancer Screening in a Real World Setting
Lead sponsor
Freenome Holdings Inc.
Phase
Observational
Overall status
Completed
Start date
September 6, 2022
Completion date
May 2, 2024
Enrollment
788 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

newly-diagnosed cancers, non-cancer controls